Healing Ointment Usage Post-surgical Procedure

NCT05686928 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-05-22

Study results available
· View outcomes & findings →

Summary

To evaluate benefits of a Healing Ointment in skin improvement after dermatologic procedures

Conditions

  • Surgical Wound

Interventions

DRUG

Cetaphil Healing Ointment

Topical ointment application twice daily

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Aaron Farberg, MD · Derm Texas and Legacy Dermatology

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-17
Primary Completion
2022-10-31
Completion
2022-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05686928 on ClinicalTrials.gov